Abstract

The role of breast MRI in patients with newly diagnosed breast cancer is controversial. Preoperative MRI is highly sensitive and accurate in assessing tumor size, extensive intraductal component (EIC), and in detection of additional sites of disease. It also has utility in assessing chest wall, nipple-areolar complex, and nodal involvement. Yet there are conflicting results in whether the use of preoperative MRI improves re-excision rate, local recurrence rate, and ultimately, survival. MRI has also been associated with overestimation of disease and increased mastectomy rates, and may contribute to treatment delay. Nevertheless, certain subgroups of patients may benefit more from preoperative MRI than others, including those with invasive lobular cancer (ILC), dense breasts, and those at elevated risk for breast cancer.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call